Review of Plant-Derived Natural Products with Anti-Tumor Activity
Author Information
Author(s): Dholwani K.K., Saluja A.K., Gupta A.R.
Primary Institution: A.R College of Pharmacy affiliated to Sardar Patel University
Hypothesis
Can plant-derived natural products and their analogs be developed into effective anti-tumor agents?
Conclusion
The study highlights the potential of plant-derived compounds, particularly GL331, as promising candidates for anticancer drug development.
Supporting Evidence
- GL331 is currently in anticancer clinical trials.
- Nine plant-derived compounds have been approved for use as anticancer drugs in the US since 1961.
- Preclinical screening identifies promising drug development targets.
Takeaway
Scientists are looking at plants to find new medicines that can help fight cancer. One promising candidate is GL331, which is being tested in people.
Methodology
The study involved bioactivity-directed isolation, characterization, and modification of plant-derived compounds, followed by preclinical screening in human cell lines and xenograft models.
Limitations
The review does not provide specific quantitative data on the efficacy of the compounds discussed.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website